ClinicalTrials.gg
RecruitingNCT05923138BOCADOS-ICUpdated Nov 22, 2023

Nutritional Approach in Adults Followed up in Spanish Hospitals for Heart Failure (BOCADOS-IC)

An interventional study of MULTIDOMAIN NUTRITIONAL INTERVENTION: DIET, EXERCISE AND NUTRITIONAL SUPPLEMENTS and CONTROL in Heart Failure, sponsored by Spanish Society of Cardiology. Recruiting at 1 site in Spain. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2023-11-22.

Sponsored by Spanish Society of Cardiology · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years 2 months ago, but the record still lists the study as recruiting.
  • Started Nov 2023; still recruiting 3 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
264
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 342 studies in Heart Failure with a site in Spain — 76 open to participants now, 99 under way, 21 of them phase 3. Heart Failure · Spain.

Planned enrollment
138th of 263
264 · median 294
Started
2023
with 18 others
No phase
119 of 342
34 open now
Primary completion
2024-09
later than 7 of 98 live
Registered
251st of 342
by date

Among the 342 studies in Heart Failure with a site in Spain, this one is the 138th largest by planned enrollment of the 263 interventional ones that give a count, is one of 19 that started in 2023, is one of 119 with no phase, reaches primary completion later than 7 of the 98 other live ones, and was the 251st registered.

Heart Failure

6,340 studies on the registry are indexed under Heart Failure; 1,397 are open to participants now.

Browse Heart Failure studies →

Open to participants now

76 of the 342 studies in Heart Failure with a site in Spain are open now. Recruiting first, the newest first:

71 more — sign in →

All 76 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 968 Heart Failure studies recruiting now, 691 (71%) set no upper age limit and 90 (9%) stop at 75 or younger; 64 take children under 18; 97 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 342 studies in Heart Failure with a site in Spain, or all of them as a file.
02

Study summary

This is a randomized, controlled, open-label, prospective, multicentre clinical trial designed to assess the effects of a nutritional intervention on morbidity and mortality in patients with chronic heart failure.

Through a simple 1:1 randomization process, patients will be assigned to the control group or the intervention group. Patients in the intervention group will undergo an individualised nutritional intervention program consisting of 3 pillars: diet optimization, specific recommendations ,and nutritional supplementation if nutritional targets are not achieved.

03

Conditions studied

  • Heart Failure

Keywords

  • HEART FAILURE
  • MALNUTRITION
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients older than 65 years with malnutrition (MNA-SF score ≤ 11) with chronic ambulatory heart failure (HF).

Exclusion criteria

Exclusion Criteria:

  • Admission for heart failure (HF) in the last month,
  • Chronic renal failure on dialysis.
  • Patients already on nutritional treatment.
  • Concomitant diseases which, apart from the HF itself, could lead to a of less than 1 year,
  • Patients included in other clinical trials.
  • Patients whose clinical situation makes it impossible to perform a nutritional assessment according to the design established in the study protocol or who do not give their consent for this purpose.
  • Patients who during admission undergo surgical or percutaneous treatment to correct the cause of acute HF,
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
264 participants (estimated)

Study arms

  • Experimental
    NUTRITIONAL INTERVENTION

    Dietary Supplement: MULTIDOMAIN NUTRITIONAL INTERVENTION: DIET, EXERCISE AND NUTRITIONAL SUPPLEMENTS

  • Placebo comparator
    CONTROL

    Dietary Supplement: CONTROL

Interventions

  • Dietary supplementMULTIDOMAIN NUTRITIONAL INTERVENTION: DIET, EXERCISE AND NUTRITIONAL SUPPLEMENTS

    Nutritional intervention (diet, dietetic recommendations and/or supplements). Participants will receive specific recommendations about diet, energetic dietetic supplementation, oral nutritional supplements, exercise... The "Nutrition Team" (formed by cardiologists, dieticians, nurses...) will closely monitor patients with periodic visits and reassessment of nutritional status and compliance with recommendations.

    Also known as: NUTRITION TEAM

  • Dietary supplementCONTROL

    Standard treatment (usual recommendations in patients with heart failure)

06

What researchers measure

Primary outcomes

  1. COMBINED EVENT

    Time to the combined event of all-cause mortality or admission for heart failure at 6 months

    Time frame: 6 MONTHS

Secondary outcomes

  1. Time to 6-month cardiovascular mortality

    Time frame: 6 MONTHS

  2. Time to all-cause admission at 6 months

    Time frame: 6 MONTHS

  3. Changes in quality of life at 3 and 6 months post-intervention

    Changes in the scores of Minnesota living with heart failure questionnaire

    Time frame: 6 MONTHS

  4. Changes in nutritional status at 3 and 6 months post intervention

    Changes in the scores of Mini Nutritional Assessment Short Form

    Time frame: 6 MONTHS

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2023 (actual). Primary completion is estimated for Sep 2024, 10 months after the start.

Of 1,119 non-industry interventional studies with no phase under Heart Failure, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 50. This study's planned 10 months is below that.

Counting every sponsor, half of 1,355 studies reached it within 31 months; a quarter within 16 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 9, 2023
First posted
Jun 28, 2023
StartActual
Nov 2, 2023
Primary completionEst.
Sep 2024
CompletionEst.
Dec 2024
Last update
Nov 22, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05923138
Lead sponsor
Spanish Society of Cardiology
Responsible party
JOSE ANGEL PEREZ RIVERA (Principal Investigator, Spanish Society of Cardiology) — Principal investigator
First posted
Jun 28, 2023
Start date
Nov 2, 2023
Primary completion
Sep 2024 (estimated)
Completion
Dec 2024 (estimated)
Last update
Nov 22, 2023

Study contacts

JOSE ANGEL PEREZ-RIVERA
Contact
JANGEL.PEREZRIVERA@GMAIL.COM
+34947281800 ext. 35756

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion